Get started
STAAR Surgical CompanySTAAR Surgical CompanySTAAR Surgical Company

STAAR Surgical Company

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

STAA chart


Full chart

STAA upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.31 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
60.79
Basic EPS (TTM)
0.44 USD
Net income (FY)
‪21.35 M‬ USD
Revenue (FY)
‪322.42 M‬ USD
Shares float
‪48.96 M‬
Beta (1Y)
0.61

Employees


Employees (FY)
‪1.11 K‬
Change (1Y)
+151 +15.66%
Revenue / Employee (1Y)
‪289.16 K‬ USD
Net income / Employee (1Y)
‪19.15 K‬ USD

About STAAR Surgical Company


Sector
Health Technology
Industry
Medical Specialties
CEO
Thomas G. Frinzi
Website
staar.com
Headquarters
Lake Forest
Founded
1982
FIGI
BBG000C4QB95
STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

STAA news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of STAA is 26.68 USD — it has increased by 0.19% in the past 24 hours. Watch STAAR Surgical Company stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange STAAR Surgical Company stocks are traded under the ticker STAA.
STAA stock has fallen by −3.23% compared to the previous week, the month change is a −12.12% fall, over the last year STAAR Surgical Company has showed a −21.18% decrease.
We've gathered analysts' opinions on STAAR Surgical Company future price: according to them, STAA price has a max estimate of 51.00 USD and a min estimate of 27.00 USD. Watch STAA chart and read a more detailed STAAR Surgical Company stock forecast: see what analysts think of STAAR Surgical Company and suggest that you do with its stocks.
STAA reached its all-time high on Sep 7, 2021 with the price of 163.08 USD, and its all-time low was 0.79 USD and was reached on Apr 7, 2009. View more price dynamics on STAA chart.
See other stocks reaching their highest and lowest prices.
STAA stock is 2.76% volatile and has beta coefficient of 0.61. Track STAAR Surgical Company stock price on the chart and check out the list of the most volatile stocks — is STAAR Surgical Company there?
Today STAAR Surgical Company has the market capitalization of ‪1.31 B‬, it has decreased by −0.11% over the last week.
Yes, you can track STAAR Surgical Company financials in yearly and quarterly reports right on TradingView.
STAAR Surgical Company is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
STAA earnings for the last quarter are 0.26 USD per share, whereas the estimation was 0.18 USD resulting in a 44.56% surprise. The estimated earnings for the next quarter are −0.03 USD per share. See more details about STAAR Surgical Company earnings.
STAAR Surgical Company revenue for the last quarter amounts to ‪88.59 M‬ USD, despite the estimated figure of ‪86.90 M‬ USD. In the next quarter, revenue is expected to reach ‪77.19 M‬ USD.
STAA net income for the last quarter is ‪9.98 M‬ USD, while the quarter before that showed ‪7.38 M‬ USD of net income which accounts for 35.25% change. Track more STAAR Surgical Company financial stats to get the full picture.
No, STAA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has ‪1.11 K‬ employees. See our rating of the largest employees — is STAAR Surgical Company on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. STAAR Surgical Company EBITDA is ‪31.59 M‬ USD, and current EBITDA margin is 10.30%. See more stats in STAAR Surgical Company financial statements.
Like other stocks, STAA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade STAAR Surgical Company stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So STAAR Surgical Company technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating STAAR Surgical Company stock shows the sell signal. See more of STAAR Surgical Company technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.